With your support, we have been able to fund outstanding research, leading toward cures and improved quality of life for children with cancer. Browse through more than 1,000 funded projects below.
Use the search tool to refine your results. You can also click on a heading to sort by project title, institution name, or year the grant was awarded. Click on the project title to read more information.
You can learn about ALSF's grant review process here.
ALSF Funded Research Projects
|Project Title||Institution / Principal Investigator(s)||Grant Type||Year||State|
|Epigenetic regulation of genomic instability and its therapeutic implications in T-cell acute lymphoblastic leukemia||Dana-Farber Cancer Institute / Birgit Knoechel, MD/PhD||Innovation Grants||2019||Massachusetts|
|Selectively targeting EP300 with small molecules for neuroblastoma (NB) therapy||Dana-Farber Cancer Institute / Jun Qi, PhD||Innovation Grants||2019||Massachusetts|
|Predicting and Overcoming Resistance to Immunotherapy in Pediatric High-Grade Glioma||Ann & Robert H. Lurie Children's Hospital of Chicago / Oren Becher, MD & Robert Wechsler-Reya, PhD||Innovation Grants||2019||Illinois|
|Role of the macro lncRNA KCNQ1OT1 in embryonal rhabdomyosarcoma tumorigenesis||Duke University / Corinne Linardic, MD/PhD||Innovation Grants||2019||North Carolina|
|Saturating CRISPR gene body scans in MLL-rearranged leukemia||Beckman Research Institute of City of Hope / Chun-Wei Chen, PhD||Innovation Grants||2019||California|
|Pediatric Osteosarcoma: Identifying the elusive molecular signature and its relationship to this disease||St. Jude Children's Research Hospital / Linda Hendershot, PhD||Innovation Grants||2019||Tennessee|
|Novel Therapy of Heterogeneous B-cell Acute Lymphocytic Leukemia by Targeting Convergent Oncogenic Mediators STATs||University of Alberta / Hasan Uludag, PhD||Innovation Grants||2019||Alberta|
|Targeting microenvironment-induced TGFB signaling to overcome drug resistance in acute lymphoblastic leukemia||St. Jude Children's Research Hospital / Charles Mullighan, MD||Innovation Grants||2019||Tennessee|
|Norepinephrine Transporter-Targeted Pharmacotherapy of Aggressive Neuroblastoma||Children's Hospital of Philadelphia / Michael Chorny, PhD||Innovation Grants||2019||Pennsylvania|
|Therapeutic Targeting of the Disrupted Metabolic State in DIPG||University of Michigan / Costas Lyssiotis, PhD & Sriram Venneti, MD/PhD||Innovation Grants||2019||Michigan|